← Back to Search

Vocational Rehabilitation for Opioid Use Disorder (THRIVE Trial)

N/A
Recruiting
Led By Mercy N Mumba, RN
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 19* (<19 year of age in the state of AL is defined minor)
Currently unemployed or underemployed, defined as working <20hrs/week in a meaningful competitive job for a wage, salary, or commission
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 months
Awards & highlights

THRIVE Trial Summary

This trial is testing whether getting and keeping a job helps Veterans with opioid use problems in other areas of their life.

Who is the study for?
This trial is for Veterans aged 19 or older with opioid use disorder who are unemployed or underemployed, working less than 20 hours a week. They must want to work and be able to consent to the study. Those with severe medical conditions, active suicidal thoughts, involvement in other vocational trials, psychotic disorders, dementia, or anticipated inability to complete the study cannot participate.Check my eligibility
What is being tested?
The trial aims to assist Veterans with opioid problems by comparing two employment support methods: Treatment As Usual Vocational Rehabilitation (TAU-VR) and Individual Placement and Support (IPS). It will evaluate how these approaches affect their ability to find and keep jobs as well as improve overall wellbeing.See study design
What are the potential side effects?
Since this trial focuses on employment support rather than medication, it does not have typical 'side effects.' However, participants may experience stress or anxiety related to job searching and maintaining employment during the course of the intervention.

THRIVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 19 years old or older.
Select...
I am currently working less than 20 hours a week.

THRIVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
number of weeks worked
Secondary outcome measures
Anxiety
Depression
Quality of Life
+2 more
Other outcome measures
suicide risk

THRIVE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Individual Placement and SupportExperimental Treatment1 Intervention
The IPS model involves the following important domains: competitive employment, eligibility based on client choice of employment, integration of IPS and treatment team personalized counseling, rapid job search, systematic job development, and time-unlimited and individualized support.
Group II: Treatment As Usual Vocational Rehabilitation (TAU-VR)Active Control1 Intervention
TAU-VR Services may include 1) Compensated Work Therapy-Transitional Work (CWT-TW) assignment in a set-aside, minimum-wage, short-term job, typically in the VA setting (approximately 50% of the Veterans randomized to TW in past studies conducted by the investigators actually engaged in TW assignment) or 2) CWT-Community-Based Employment Services (CWT-CBES) which involves a community job search, placement in a competitive job, with limited follow-along support that typically ends after the Veteran is working in his/her first job

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,309 Total Patients Enrolled
Mercy N Mumba, RNPrincipal InvestigatorTuscaloosa VA Medical Center, Tuscaloosa, AL

Media Library

Individual Placement and Support (IPS) Clinical Trial Eligibility Overview. Trial Name: NCT05388812 — N/A
Opioid Use Disorder Research Study Groups: Treatment As Usual Vocational Rehabilitation (TAU-VR), Individual Placement and Support
Opioid Use Disorder Clinical Trial 2023: Individual Placement and Support (IPS) Highlights & Side Effects. Trial Name: NCT05388812 — N/A
Individual Placement and Support (IPS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05388812 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for recruitment into this research project at present?

"The clinicaltrials.gov registry shows that this medical trial, which was initially advertised on February 1st 2023, is not currently enrolling patients. However, 535 other studies are actively recruiting at the moment."

Answered by AI
~76 spots leftby Aug 2026